Thinking of joining a study?

Register your interest

NCT04944160 | COMPLETED | RSV Infection


Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic
Sponsor:

Civil Hospices of Lyon

Brief Summary:

The magnitude of seasonal Respiratory Syncytial Virus (RSV) epidemics brings each year new logistical challenges for the hospitalization of young infants with bronchiolitis that overwhelm hospital capacities and lead to specific winter plans with deprogramming and mobilization of human and logistical resources. The Covid-19 pandemic has changed the way winter epidemics are presented. For example, the seasonal RSV epidemic was shifted by several months in Lyon, with an impression of a lower incidence of hospitalized cases, with a population of older children and with fewer signs of clinical severity. This is largely attributable to the widespread use of barrier gestures and social distancing measures, known as "Non-Pharmacological Interventions" (NPI). Given the magnitude of the reduction of the RSV epidemic, it is legitimate to analyze the benefits of NPIs to draw lessons for maintaining preventive measures around RSV-vulnerable populations; moreover, new preventive pharmacological interventions are soon to be marketed, whether they are particularly refined and long half-life anti-RSV monoclonal antibodies, RSV vaccines for mothers or for newborns and infants. In this perspective, it is crucial to properly define the populations at risk of severe disease to establish a legitimate hierarchy in the implementation of different preventive strategies. The study of the RSV epidemic is a high potential model because of the convergence of epidemiological, virological, and pharmacological knowledge. However, the study of the impact of the pandemic on the epidemiology of rhinovirus also seems promising because, for reasons unknown to date, it seems that the pandemic did not have the same reducing impact on the rhinovirus epidemic; in the latter case, the interest is to confirm the resistance of this virus and to look for more fundamental explanations, for example, on viral interactions.

Condition or disease

RSV Infection

Intervention/treatment

Medical records analysis

Comparison of cohorts

Study Type : OBSERVATIONAL
Estimated Enrollment : 600 participants
Official Title : Impact of the Covid-19 Pandemic on the Epidemiology of Respiratory Syncytial Virus
Actual Study Start Date : 2021-03-15
Estimated Primary Completion Date : 2021-05-15
Estimated Study Completion Date : 2021-06-28

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: to 5 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * • Child hospitalized at " Hôpital Femme Mère Enfant ", Lyon, France
  • * Polymerase Chain Reaction (PCR) positive at Respiratory Syncytial Virus (RSV)
Exclusion Criteria
  • * • Parent's refusal to participate

Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic

Location Details

NCT04944160


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

France,

EST Hospital Group - Hospices Civils de Lyon

Bron, France, 69500

Loading...